dabigatran etexilate mesylate
Pharmaranks rates Dabigatran Etexilate Mesylate 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Dabigatran Etexilate Mesylate is a direct thrombin inhibitor used to treat Pulmonary Embolism, Venous Thrombosis.
Direct Thrombin Inhibitor · by Breckenridge
Generic of Pradaxa
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Dabigatran Etexilate Mesylate
- Drug class
- Direct Thrombin Inhibitor
- Form
- Capsule
- Strength
- Dabigatran Etexilate Mesylate EQ 110MG Base · Dabigatran Etexilate Mesylate EQ 150MG Base · Dabigatran Etexilate Mesylate EQ 75MG Base
- Type
- Prescription (Rx)
- Brand or generic
- Generic
- May treat
- pulmonary embolism, venous thrombosis
- Manufacturer
- Breckenridge
- What the pharmacy pays
- ~$27.04 for 30 — not your price
- FDA application
- ANDA207922
- Availability
- Discontinued (per FDA)
Drug class
May treat (source: NIH RxClass)
Dosage forms
Capsule
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Dabigatran Etexilate Mesylate treat?
- Dabigatran Etexilate Mesylate (Dabigatran Etexilate Mesylate) may be used to treat pulmonary embolism, venous thrombosis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Dabigatran Etexilate Mesylate rated?
- pharmaranks gives Dabigatran Etexilate Mesylate a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- How much does Dabigatran Etexilate Mesylate cost?
- Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $27.04 for 30, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins.
- Is there a coupon or discount for Dabigatran Etexilate Mesylate?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Dabigatran Etexilate Mesylate. To pay less, Dabigatran Etexilate Mesylate is already a generic — usually the lowest-cost version — so the main levers are comparing cash prices between pharmacies and using a pharmacy discount-card service. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Dabigatran Etexilate Mesylate?
- Dabigatran Etexilate Mesylate is marketed by Breckenridge. You can see Breckenridge's full profile, rating, and other products on pharmaranks.
- Is Dabigatran Etexilate Mesylate a brand-name or generic drug?
- Dabigatran Etexilate Mesylate is a generic medication; its active ingredient is Dabigatran Etexilate Mesylate. Generics contain the same active ingredient as the brand-name original and are usually lower cost.
- Is Dabigatran Etexilate Mesylate available over the counter?
- No. Dabigatran Etexilate Mesylate is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Dabigatran Etexilate Mesylate come in?
- Dabigatran Etexilate Mesylate is currently marketed as capsule, per the FDA's National Drug Code Directory.
- What class of drug is Dabigatran Etexilate Mesylate?
- Dabigatran Etexilate Mesylate is classified as direct thrombin inhibitor, per the FDA's Established Pharmacologic Class.
- Is Dabigatran Etexilate Mesylate FDA-registered?
- Dabigatran Etexilate Mesylate is on record with the U.S. FDA under application number ANDA207922. You can verify this on its official FDA label.
- Has Dabigatran Etexilate Mesylate been recalled by the FDA?
- Dabigatran Etexilate Mesylate has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Dabigatran Etexilate Mesylate safe?
- There's no single safe-or-not verdict. pharmaranks gives Dabigatran Etexilate Mesylate a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Dabigatran Etexilate Mesylate head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
dabigatran etexilate mesylate
70/100